article thumbnail

Why early participant engagement is now a top priority in genetic disease research

pharmaphorum

In our experience of running 20+ precision medicine studies, there are a few design principles that every research programme – from biobanks to clinical trials – should consider. And if participants have opted in to be made aware of their risks of genetic diseases, then communication has to be carefully considered.

article thumbnail

HFpEF vs. HFrEF: How To Improve Heart Failure Drug Development

XTalks

A 2015 study published in Nature Genetics found that the availability of human genetic data made investigational drugs twice as likely to pass pivotal trials and eventually be approved.